Skip to content
Home/Companies/Biotech/Northsea Therapeutics
Northsea Therapeutics

Northsea Therapeutics

Biotech·NL·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Northsea Therapeutics?

Northsea Therapeutics is currently owned by Ysios Capital Partners through Ysios BioFund III (2020 vintage), since 2021. Across its history, Northsea Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-03

Ysios Capital Partners
Most recent investor
Ysios Capital Partners
Ysios BioFund III · 2020 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQNL
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Novo Holdings and Ysios Capital Partners since 2017.
Co-invest · 2 holders · 2017 · present
Novo Holdings
2017 · present(9yr) · Novo Holdings Venture Investments · 1999 · VC
Ysios Capital Partners
2021 · present(5yr) · Ysios BioFund III · 2020 · Life Sciences VC
Track Northsea Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Northsea Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Northsea Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue